Generic Nicotine Replacement Products Start To Smoke In 2000
This article was originally published in The Tan Sheet
Executive Summary
Private label OTC smoking cessation products thrived in 2000, their first full year on the food, drug and mass market, recording sales well over $100 mil. and capturing nearly a 20% dollar share, according to data from Information Resources, Inc. (Chicago).
You may also be interested in...
Commit Lozenge Generic Equivalent Application Filed
A recent regulatory submission filed with FDA is seeking 180-day exclusivity for a generic version of nicotine replacement therapy lozenges
Commit Lozenge Generic Equivalent Application Filed
A recent regulatory submission filed with FDA is seeking 180-day exclusivity for a generic version of nicotine replacement therapy lozenges
Commit Lozenge Generic Equivalent Application Filed
A recent regulatory submission filed with FDA is seeking 180-day exclusivity for a generic version of nicotine replacement therapy lozenges